EVO logo

Evotec SE (EVO) EBITDA

Annual EBITDA

$26.12 M
+$88.50 M+141.87%

December 31, 2023

Summary

Performance

1-Year Change

+141.87%

3-Year Change

-74.69%

5-Year Change

-79.11%

15-Year Change

-51.54%

EVO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.67%
EVO annual EBITDA is higher than 83.67% of companies in Healthcare sector

High & Low

All-time High

$371.33 M
EVO annual EBITDA is currently -92.97% below its historical high of $371.33 million

3-Year Low

-$62.38 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
EVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 24, 2025
EVO next annual earnings announcement is scheduled for Apr 24, 2025

OtherEVOprofitabilitymetrics:

Annual Revenue

$845.98 M
EVO annual revenue is $845.98 million

Annual Net Income

-$90.84 M
EVO annual net profit is -$90.84 million

Annual EBIT

-$74.54 M
EVO annual earnings before interest & taxes is -$74.54 million

Annual EPS

-$0.25
EVO annual earnings per share is -$0.25

Quarterly EBITDA

-$49.50 M
+$60.02 M+54.80%

September 1, 2024

Summary

Performance

3-Month Change

+54.8%

1-Year Change

-72.24%

3-Year Change

+31.7%

5-Year Change

+31.7%

EVO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.73%
EVO quarterly EBITDA is higher than 8.73% of companies in Healthcare sector

High & Low

All-time High

$167.81 M
EVO quarterly EBITDA is currently -129.50% below its historical high of $167.81 million

3-Year Low

-$109.52 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
EVO previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Apr 24, 2025
EVO next earnings announcement is scheduled for Apr 24, 2025

OtherEVOprofitabilitymetrics:

Quarterly Revenue

$203.34 M
EVO quarterly revenue is $203.34 million

Quarterly Net Income

-$43.59 M
EVO quarterly net profit is -$43.59 million

Quarterly EBIT

-$49.50 M
EVO quarterly earnings before interest & taxes is -$49.50 million

Quarterly EPS

-$0.12
EVO quarterly earnings per share is -$0.12

TTM EBITDA

-$207.65 M
-$20.76 M-11.11%

September 1, 2024

Summary

Performance

3-Month Change

-11.11%

1-Year Change

-206.11%

3-Year Change

-235.65%

5-Year Change

-235.65%

EVO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

7.46%
EVO TTM EBITDA is higher than 7.46% of companies in Healthcare sector

High & Low

All-time High

$321.77 M
EVO TTM EBITDA is currently -164.53% below its historical high of $321.77 million

3-Year Low

-$207.65 M
EVO TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
EVO previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Apr 24, 2025
EVO next earnings announcement is scheduled for Apr 24, 2025

OtherEVOprofitabilitymetrics:

TTM Revenue

$842.96 M
EVO TTM revenue is $842.96 million

TTM Net Income

-$185.63 M
EVO TTM net profit is -$185.63 million

TTM EBIT

-$207.65 M
EVO TTM earnings before interest & taxes is -$207.65 million

TTM EPS

-$0.53
EVO TTM earnings per share is -$0.53

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$26.12 M
EVO annual EBITDA is $26.12 million

Annual Net Income

-$90.84 M
EVO annual net profit is -$90.84 million

Annual Interest Expense

$12.71 M
EVO annual interest expense is $12.71 million

Annual Income Tax

$3.59 M
EVO annual income tax is $3.59 million

Annual D&A

$100.66 M
EVO annual depreciation & amortization is $100.66 million

EVO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+141.9%-72.2%-206.1%
3 y3 years-74.7%+31.7%-235.7%
5 y5 years-79.1%+31.7%-235.7%

EVO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-93.0%+141.9%-1139.9%+54.8%-170.6%at low
5 y5-year-93.0%+141.9%-129.5%+54.8%-164.5%at low
alltimeall time-93.0%+125.4%-129.5%+54.8%-164.5%at low

Evotec SE EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$49.50 M(-54.8%)
-$207.65 M(+11.1%)
Jun 2024
-
-$109.52 M(+318.2%)
-$186.89 M(+92.9%)
Mar 2024
-
-$26.19 M(+16.7%)
-$96.89 M(+29.7%)
Dec 2023
$26.12 M(-141.9%)
-$22.45 M(-21.9%)
-$74.69 M(+10.1%)
Sep 2023
-
-$28.74 M(+47.3%)
-$67.84 M(-14.9%)
Jun 2023
-
-$19.52 M(+388.8%)
-$79.70 M(-3.0%)
Mar 2023
-
-$3.99 M(-74.4%)
-$82.20 M(-45.4%)
Dec 2022
-$62.38 M(-116.8%)
-$15.59 M(-61.6%)
-$150.68 M(-0.9%)
Sep 2022
-
-$40.61 M(+84.4%)
-$152.04 M(-369.7%)
Jun 2022
-
-$22.02 M(-69.6%)
$56.38 M(-63.2%)
Mar 2022
-
-$72.47 M(+327.5%)
$153.08 M(-47.9%)
Dec 2021
$371.33 M(+259.8%)
-$16.95 M(-110.1%)
$293.94 M(-8.6%)
Sep 2021
-
$167.81 M(+124.7%)
$321.77 M(+95.8%)
Jun 2021
-
$74.69 M(+9.2%)
$164.33 M(+93.8%)
Mar 2021
-
$68.39 M(+528.6%)
$84.79 M(+110.6%)
Dec 2020
$103.20 M(-18.4%)
$10.88 M(+4.8%)
$40.26 M(+12.5%)
Sep 2020
-
$10.38 M(-313.8%)
$35.79 M(-28.9%)
Jun 2020
-
-$4.85 M(-120.3%)
$50.31 M(-15.3%)
Mar 2020
-
$23.86 M(+272.3%)
$59.40 M(+5.2%)
Dec 2019
$126.43 M(+1.1%)
$6.41 M(-74.3%)
$56.47 M(-17.8%)
Sep 2019
-
$24.89 M(+487.2%)
$68.69 M(-20.8%)
Jun 2019
-
$4.24 M(-79.7%)
$86.75 M(-15.4%)
Mar 2019
-
$20.93 M(+12.4%)
$102.50 M(+17.8%)
Dec 2018
$125.03 M(+132.0%)
$18.62 M(-56.6%)
$87.05 M(+11.5%)
Sep 2018
-
$42.95 M(+114.9%)
$78.05 M(+94.5%)
Jun 2018
-
$19.99 M(+265.0%)
$40.12 M(+56.5%)
Mar 2018
-
$5.48 M(-43.1%)
$25.63 M(-15.0%)
Dec 2017
$53.90 M(+5.0%)
$9.63 M(+91.7%)
$30.14 M(-16.6%)
Sep 2017
-
$5.02 M(-8.8%)
$36.13 M(-18.5%)
Jun 2017
-
$5.50 M(-44.9%)
$44.33 M(-5.8%)
Mar 2017
-
$9.99 M(-36.1%)
$47.08 M(+23.8%)
Dec 2016
$51.32 M
$15.62 M(+18.2%)
$38.02 M(+68.6%)
Sep 2016
-
$13.22 M(+60.1%)
$22.55 M(+166.1%)
Jun 2016
-
$8.26 M(+787.8%)
$8.48 M(-52.1%)
DateAnnualQuarterlyTTM
Mar 2016
-
$930.00 K(+525.0%)
$17.70 M(+12.9%)
Dec 2015
$29.03 M(+336.7%)
$148.80 K(-117.3%)
$15.68 M(-24.9%)
Sep 2015
-
-$859.10 K(-104.9%)
$20.88 M(+18.8%)
Jun 2015
-
$17.48 M(-1710.3%)
$17.58 M(+1731.7%)
Mar 2015
-
-$1.09 M(-120.3%)
$959.70 K(-151.8%)
Dec 2014
$6.65 M(-139.7%)
$5.35 M(-228.5%)
-$1.85 M(-93.7%)
Sep 2014
-
-$4.16 M(-584.7%)
-$29.39 M(+18.1%)
Jun 2014
-
$858.60 K(-122.0%)
-$24.89 M(-7.0%)
Mar 2014
-
-$3.90 M(-82.4%)
-$26.78 M(+6.5%)
Dec 2013
-$16.75 M(-330.2%)
-$22.19 M(-6665.3%)
-$25.16 M(+139.3%)
Sep 2013
-
$338.00 K(-132.8%)
-$10.51 M(+24.6%)
Jun 2013
-
-$1.03 M(-54.7%)
-$8.44 M(+398.3%)
Mar 2013
-
-$2.27 M(-69.9%)
-$1.69 M(+154.9%)
Dec 2012
$7.28 M(-60.8%)
-$7.55 M(-413.0%)
-$664.40 K(-136.7%)
Sep 2012
-
$2.41 M(-57.8%)
$1.81 M(-86.5%)
Jun 2012
-
$5.72 M(-559.5%)
$13.41 M(+22.7%)
Mar 2012
-
-$1.24 M(-75.5%)
$10.94 M(-14.2%)
Dec 2011
$18.57 M(+36.8%)
-$5.07 M(-136.2%)
$12.75 M(-43.3%)
Sep 2011
-
$14.02 M(+332.8%)
$22.51 M(+131.7%)
Jun 2011
-
$3.24 M(+466.4%)
$9.71 M(+5.6%)
Mar 2011
-
$571.80 K(-87.8%)
$9.20 M(+30.2%)
Dec 2010
$13.57 M(-124.6%)
$4.68 M(+282.5%)
$7.06 M(-152.8%)
Sep 2010
-
$1.22 M(-55.1%)
-$13.39 M(-30.5%)
Jun 2010
-
$2.72 M(-274.5%)
-$19.26 M(-42.4%)
Mar 2010
-
-$1.56 M(-90.1%)
-$33.45 M(-44.3%)
Dec 2009
-$55.23 M(-46.2%)
-$15.77 M(+239.1%)
-$60.09 M(-44.1%)
Sep 2009
-
-$4.65 M(-59.4%)
-$107.44 M(+0.8%)
Jun 2009
-
-$11.46 M(-59.4%)
-$106.57 M(+12.0%)
Mar 2009
-
-$28.21 M(-55.3%)
-$95.11 M(+10.1%)
Dec 2008
-$102.75 M(+1174.6%)
-$63.12 M(+1567.5%)
-$86.36 M(+271.5%)
Sep 2008
-
-$3.79 M(-80.5%)
-$23.24 M(+19.5%)
Mar 2008
-
-$19.46 M
-$19.46 M
Dec 2007
-$8.06 M(-71.0%)
-
-
Dec 2006
-$27.84 M(+21.3%)
-
-
Dec 2005
-$22.94 M
-
-

FAQ

  • What is Evotec SE annual EBITDA?
  • What is the all time high annual EBITDA for Evotec SE?
  • What is Evotec SE annual EBITDA year-on-year change?
  • What is Evotec SE quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Evotec SE?
  • What is Evotec SE quarterly EBITDA year-on-year change?
  • What is Evotec SE TTM EBITDA?
  • What is the all time high TTM EBITDA for Evotec SE?
  • What is Evotec SE TTM EBITDA year-on-year change?

What is Evotec SE annual EBITDA?

The current annual EBITDA of EVO is $26.12 M

What is the all time high annual EBITDA for Evotec SE?

Evotec SE all-time high annual EBITDA is $371.33 M

What is Evotec SE annual EBITDA year-on-year change?

Over the past year, EVO annual EBITDA has changed by +$88.50 M (+141.87%)

What is Evotec SE quarterly EBITDA?

The current quarterly EBITDA of EVO is -$49.50 M

What is the all time high quarterly EBITDA for Evotec SE?

Evotec SE all-time high quarterly EBITDA is $167.81 M

What is Evotec SE quarterly EBITDA year-on-year change?

Over the past year, EVO quarterly EBITDA has changed by -$20.76 M (-72.24%)

What is Evotec SE TTM EBITDA?

The current TTM EBITDA of EVO is -$207.65 M

What is the all time high TTM EBITDA for Evotec SE?

Evotec SE all-time high TTM EBITDA is $321.77 M

What is Evotec SE TTM EBITDA year-on-year change?

Over the past year, EVO TTM EBITDA has changed by -$139.82 M (-206.11%)